Original article
Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics

https://doi.org/10.1016/0091-6749(87)90365-4Get rights and content

Abstract

A 15-year-old patient with cystic fibrosis developed urticarial reactions to tobramycin, gentamicin, and cephoperazone, and an anaphylactic reaction to ticarcillin during therapy for an extensive pulmonary infection with Pseudomonas aeruginosa and Staphylococcus aureus. Immediate wheal-and-flare skin tests were positive with tobramycin and with penicilloylpoly-l-lysine. Desensitization with tobramycin in gradually increasing intravenous doses was accomplished during 8 hours. The procedure was complicated by a macular rash that remitted within minutes without therapy, but no symptoms or signs of an allergic reaction to tobramycin were detected during full dose therapy. Skin test responses to tobramycin became negative by the end of the desensitization procedure, whereas the responses to penicilloylpoly-l-lysine and histamine remained positive. A worsening course led to an unsuccessful attempt to desensitize the patient to β-lactam determinants. Wheezing appeared during the administration of oral doses. This case demonstrates the feasibility of acute, antigen-specific desensitization of an aminoglycoside-allergic patient and the failure to achieve a second, simultaneous desensitization. This patient experienced the first serious reaction to oral penicillin desensitization.

References (38)

  • LA Brown et al.

    Long-term ticarcillin desensitization by the continuous oral administration of penicillin

    J Allergy Clin Immunol

    (1982)
  • RM Maulitz et al.

    Exercise-induced anaphylactic reaction to shellfish

    J Allergy Clin Immunol

    (1979)
  • JM Kidd et al.

    Food-dependent exercise-induced anaphylaxis

    J Allergy Clin Immunol

    (1983)
  • KA Arndt et al.

    Rates of cutaneous reactions to drugs

    JAMA

    (1976)
  • JR Caldwell et al.

    Adverse reactions to antimicrobial agents

    JAMA

    (1974)
  • GD Wendel et al.

    Penicillin allergy and desensitization in serious infections during pregnancy

    N Engl J Med

    (1985)
  • ME Hodson

    Cystic fibrosis

    Postgrad Med J

    (1984)
  • TJ Sullivan

    Advances in the diagnosis and management of penicillin allergy

  • AA Fisher

    Adverse reactions to bacitracin, polymyxin, and gentamicin sulfate

    Cutis

    (1983)
  • Cited by (64)

    • Pediatric Drug Allergies: Updates on Beta-Lactam, Nonsteroidal Anti-Inflammatory Drug, and Chemotherapeutic Reactions

      2021, Immunology and Allergy Clinics of North America
      Citation Excerpt :

      Cross-reactivity between different aminoglycoside antibiotics has been shown to occur.72 Desensitization, particularly in cystic fibrosis patients, has been performed successfully.72–74 Historically, fluoroquinolone use in pediatrics has been avoided because of concern for adverse effects, although fluoroquinolone prescription rates have increased in recent years.75

    • Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs

      2020, Journal of Allergy and Clinical Immunology: In Practice
      Citation Excerpt :

      Systemic contact dermatitis to aminoglycosides, as well as severe type IV hypersensitivity reactions such as TEN and DRESS syndrome, have also been described.158-160 IgE-mediated reactions to aminoglycosides are uncommon but may occur after exposure to topical, inhaled, and systemic preparations.161-163 IgE-mediated reactions described in the literature include urticarial reactions in response to both intravenous and inhaled tobramycin, as well as anaphylaxis to topical and systemic aminoglycosides.161-163

    • Pediatric Drug Allergies: Updates on Beta-Lactam, Nonsteroidal Anti-Inflammatory Drug, and Chemotherapeutic Reactions

      2019, Pediatric Clinics of North America
      Citation Excerpt :

      Cross-reactivity between different aminoglycoside antibiotics has been shown to occur.72 Desensitization, particularly in cystic fibrosis patients, has been performed successfully.72–74 Historically, fluoroquinolone use in pediatrics has been avoided because of concern for adverse effects, although fluoroquinolone prescription rates have increased in recent years.75

    • Other Antibiotic Allergy

      2018, Drug Allergy Testing
    • Other Antibiotic Allergy

      2017, Drug Allergy Testing
    • Mucovicidosis and allergy to antibiotics

      2013, Revue Francaise d'Allergologie
    View all citing articles on Scopus
    View full text